Ambev S.A. (ABEV) Receives Average Recommendation of “Buy” from Brokerages
Shares of Ambev S.A. (NYSE:ABEV) have earned an average rating of “Buy” from the six brokerages that are currently covering the company, Marketbeat.com reports. Three equities research analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average 1-year price target among brokers that have covered the stock in the last year is $6.20.
A number of brokerages recently commented on ABEV. Zacks Investment Research downgraded Ambev from a “buy” rating to a “hold” rating in a research report on Monday, July 31st. Barclays PLC restated a “hold” rating on shares of Ambev in a research report on Sunday, July 30th.
A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Great West Life Assurance Co. Can bought a new stake in Ambev during the 1st quarter valued at $427,000. Commerzbank Aktiengesellschaft FI boosted its position in Ambev by 30.4% during the 1st quarter. Commerzbank Aktiengesellschaft FI now owns 109,334 shares of the company’s stock valued at $630,000 after acquiring an additional 25,508 shares in the last quarter. Advisors Asset Management Inc. boosted its position in Ambev by 19.2% during the 1st quarter. Advisors Asset Management Inc. now owns 113,783 shares of the company’s stock valued at $655,000 after acquiring an additional 18,343 shares in the last quarter. DekaBank Deutsche Girozentrale boosted its position in Ambev by 78.1% during the 1st quarter. DekaBank Deutsche Girozentrale now owns 57,000 shares of the company’s stock valued at $330,000 after acquiring an additional 25,000 shares in the last quarter. Finally, US Bancorp DE boosted its position in Ambev by 16.2% during the 1st quarter. US Bancorp DE now owns 423,319 shares of the company’s stock valued at $2,439,000 after acquiring an additional 58,955 shares in the last quarter. Institutional investors own 7.29% of the company’s stock.
Shares of Ambev (NYSE ABEV) opened at 6.43 on Friday. The stock’s 50 day moving average price is $6.17 and its 200-day moving average price is $5.80. The company has a market cap of $101.00 billion, a P/E ratio of 26.90 and a beta of 0.66. Ambev has a 12 month low of $4.70 and a 12 month high of $6.48.
Ambev (NYSE:ABEV) last released its quarterly earnings data on Thursday, July 27th. The company reported $0.04 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.04. The firm had revenue of $3.20 billion during the quarter, compared to analyst estimates of $3.33 billion. Ambev had a return on equity of 23.24% and a net margin of 27.14%. Equities research analysts expect that Ambev will post $0.23 earnings per share for the current year.
Ambev Company Profile
Ambev SA, formerly Inbev Participacoes Societarias SA, is a Brazil-based company engaged in the brewing sector. The Company produces and sells beer, carbonated soft drinks (CSDs) and other non-alcoholic and non-carbonated (NANC) beverages across the Americas. The Company’s activities are divided into three segments: Latin America North, including sell of beer, CSD and NANC drinks in Brazil, as well as operations in Dominican Republic, Saint Vincent, Antigua, Dominica, Guatemala, El Salvador, Nicaragua and Cuba; Latin America South, distributing products in Argentina, Bolivia, Paraguay, Uruguay, Chile, Ecuador, Peru and Colombia, and Canada, represented by Labatt’s operations, which comprises sales in Canada.
Receive News & Ratings for Ambev S.A. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ambev S.A. and related companies with MarketBeat.com's FREE daily email newsletter.